Kelli Boyd
Faculty Member
Last active: 3/20/2014

The centrosomal, putative tumor suppressor protein TACC2 is dispensable for normal development, and deficiency does not lead to cancer.

Schuendeln MM, Piekorz RP, Wichmann C, Lee Y, McKinnon PJ, Boyd K, Takahashi Y, Ihle JN
Mol Cell Biol. 2004 24 (14): 6403-9

PMID: 15226440 · PMCID: PMC434246 · DOI:10.1128/MCB.24.14.6403-6409.2004

TACC2 is a member of the transforming acidic coiled-coil-containing protein family and is associated with the centrosome-spindle apparatus during cell cycling. In vivo, the TACC2 gene is expressed in various splice forms predominantly in postmitotic tissues, including heart, muscle, kidney, and brain. Studies of human breast cancer samples and cell lines suggest a putative role of TACC2 as a tumor suppressor protein. To analyze the physiological role of TACC2, we generated mice lacking TACC2. TACC2-deficient mice are viable, develop normally, are fertile, and lack phenotypic changes compared to wild-type mice. Furthermore, TACC2 deficiency does not lead to an increased incidence of tumor development. Finally, in TACC2-deficient embryonic fibroblasts, proliferation and cell cycle progression as well as centrosome numbers are comparable to those in wild-type cells. Therefore, TACC2 is not required, nonredundantly, for mouse development and normal cell proliferation and is not a tumor suppressor protein.

MeSH Terms (15)

Animals Carrier Proteins Cell Cycle Cells, Cultured Centrosome Fibroblasts Genes, Tumor Suppressor Gene Targeting Humans Mice Mice, Knockout Neurons Survival Rate Tissue Distribution Tumor Suppressor Proteins

Connections (1)

This publication is referenced by other Labnodes entities: